Project Grant R01AG095167
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $2.7 million Project Grant to the University of California, Los Angeles (UCLA) under the Aging Research program (CFDA 93.866) to conduct a four-year comparative outcomes study examining post-acute care discharge destinations for older patients with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The research will utilize Veterans Affairs electronic health record data from approximately 100 VA...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded University of California, Irvine $6.26 million under the Aging Research program (CFDA 93.866) to establish a Discovery and Trial-Ready Cohort for Limbic-Predominant Age-Related TDP-43 Encephalopathy (TRC LATE). The grant, effective September 1, 2025, through June 30, 2030, will fund the recruitment and comprehensive characterization of 420 participants aged 85 and older across five Alzheimer's Disease Research...
- Federal Project Grant Award Summary Award Overview Northwestern University received a $670,904 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective February 15, 2026, through November 30, 2030. The award supports a longitudinal cohort study examining aging-in-place (AIP) and long-term care (LTC) decision-making among older adults with Alzheimer's dementia, building upon an existing NIA-funded cohort (LITCOG) with 293 participants...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $377,280 Project Grant to The Feinstein Institutes for Medical Research on September 20, 2025, under the Aging Research program (CFDA 93.866) to develop and deliver the STAGE Trials curriculum. This short-term educational program is designed to train a diverse, national workforce of behavioral intervention scientists in the NIH STAGE (Mechanism-Focused) conceptual model, which is essential for advancing behavioral...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Colorado-Denver a $390,000 Project Grant on August 15, 2025, under the Aging Research program (CFDA 93.866) to conduct a two-year research initiative examining serious illness communication among patients with chronic lung disease and comorbid cognitive impairment without dementia. The research project, which runs through July 31, 2027, will characterize differences in end-of-life communication outcomes...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Kaiser Foundation Hospitals' Kaiser Permanente Research Institute a $627,916 Project Grant under the Aging Research program (CFDA 93.866) effective September 15, 2025, with a completion date of June 30, 2030. This R01 research project, titled "Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs," delivers a comprehensive mixed-methods research study...
- Federal Grant Award Summary The National Institute on Aging (part of the National Institutes of Health) awarded a $243,000 Project Grant to the University of California, Los Angeles under the Aging Research program (CFDA 93.866) on August 15, 2025, with a completion date of July 31, 2030. This K76 Beeson Career Development Award supports Dr. Canales' research to develop, refine, and pilot-test the Perioperative Care Partner Program (PCPP), an intervention designed to reduce postoperative...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $770,000 Project Grant to The Leland Stanford Junior University on August 15, 2025, under the Aging Research program (CFDA 93.866) to conduct basic science research on postoperative delirium in geriatric populations. The project, titled "Targeting Aging-Related Delays in Cognitive Recovery After Anesthesia by Attenuating Oxidative Stress: Implications for Alzheimer's Disease," will investigate the mechanisms by...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Leland Stanford Junior University a $397,721 Project Grant on June 1, 2025, under the Aging Research program (CFDA 93.866) to support the EMERGED (Enhancing the Implementation, Effectiveness, and Reach of Geriatric Emergency Departments for Older Adults with Dementia) initiative. This research project will deliver comprehensive analysis and implementation guidance for Geriatric Emergency Departments (GEDs), which...
- Federal Grant Award Summary The National Institute on Aging awarded a $486,000 Project Grant on September 10, 2025, under the Aging Research program (CFDA 93.866) to Hebrew Rehabilitation Center (Hebrew Senior Life) to adapt and pilot the World Health Organization's Integrated Care for Older Persons (ICOPE) framework within post-acute skilled nursing facilities (SNFs). The primary deliverable involves developing an ICOPE-SNF protocol tailored to SNF workflows through staff interviews and...
The National Institute on Aging (NIA) awarded $632,507 to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center under the Aging Research program (CFDA 93.866) effective September 25, 2025, with completion targeted for August 31, 2030. This Project Grant supports a Type 2 hybrid effectiveness-implementation study examining the scalability and real-world implementation of Time Limited Trials (TLTs) in intensive care unit (ICU) settings. The research will be conducted across ICUs within the Los Angeles County Department of Health Services and Southern California Kaiser Permanente healthcare systems, serving diverse patient populations in the second-largest public healthcare system in the United States and the largest integrated healthcare system in Southern California. The study delivers evidence-based clinical implementation research designed to reduce potentially non-beneficial ICU treatments for critically ill patients with advanced medical illnesses through a pragmatic stepped wedge clinical trial methodology. The core service involves developing and evaluating a structured communication intervention (TLTs) that promotes shared decision-making between clinicians, patients, and surrogate decision-makers by establishing defined time periods for specific medical therapies aligned with patients' care goals. Deliverables include implementation effectiveness data, scalability assessments, identification of factors affecting intervention adoption and outcomes, and clinical evidence regarding the intervention's capacity to improve decision-making processes and reduce overutilization of invasive treatments in real-world healthcare environments.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $632.5k | 9/24/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
DC33455PO26003949S | Olive View / Ucla Education And Research Institute, Inc. | Project Grant R01AG095167 | $11.2k | 1/6/26 | |
DC33455PO26003895S | University Of Southern California | Project Grant R01AG095167 | $27.3k | 1/6/26 | |
DC33455PO26003897S | University Of California, LOS Angeles | Project Grant R01AG095167 | $26.9k | 1/5/26 |